...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Bear

Did you see my post 're DM conversation?What I reported is fact.Dutch posted and removed I suggest you should PM him for his action as it was a PM I received.If what I was told continued 3694 may extend very sick people's lives.

Share
New Message
Please login to post a reply